{"id":63651,"date":"2026-04-21T21:27:51","date_gmt":"2026-04-21T13:27:51","guid":{"rendered":"https:\/\/flcube.com\/?p=63651"},"modified":"2026-04-21T21:27:52","modified_gmt":"2026-04-21T13:27:52","slug":"upc-appeal-court-reverses-lower-ruling-imposes-preliminary-injunction-on-sinocares-icancgm-app-in-17-european-countries-following-abbott-patent-claim","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=63651","title":{"rendered":"UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim"},"content":{"rendered":"\n<p><strong>Sinocare Inc.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/300298:SHE\">SHE: 300298<\/a>) disclosed that the <strong>Court of Appeal of the Unified Patent Court (UPC)<\/strong> has overturned a prior decision by The Hague Local Division and granted a <strong>preliminary injunction<\/strong> against its <strong>iCanCGM App<\/strong>, citing alleged infringement of <strong>Abbott Laboratories\u2019<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/ABT:NYSE\">NYSE: ABT<\/a>) <strong>European Patent EP3988471<\/strong>. The injunction prohibits Sinocare from <strong>manufacturing, selling, or importing<\/strong> the disputed products across <strong>17 UPC member states<\/strong> (excluding Romania), effective immediately.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-legal-timeline-amp-key-developments\">Legal Timeline &amp; Key Developments<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Event<\/th><th>Outcome<\/th><\/tr><\/thead><tbody><tr><td><strong>July 2025<\/strong><\/td><td>Abbott files patent infringement claim at UPC over Sinocare\u2019s iCanCGM App<\/td><\/tr><tr><td><strong>Late 2025<\/strong><\/td><td>The Hague Local Division <strong>denies<\/strong> Abbott\u2019s request for preliminary injunction<\/td><\/tr><tr><td><strong>April 2026<\/strong><\/td><td>UPC Court of Appeal <strong>reverses<\/strong> lower court, <strong>grants injunction<\/strong><\/td><\/tr><tr><td><strong>Current Status<\/strong><\/td><td>Injunction in force; <strong>main infringement trial pending<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>The contested patent relates to <strong>continuous glucose monitoring (CGM) data processing and display technologies<\/strong> used in mobile health applications\u2014a core component of modern diabetes management ecosystems.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-commercial-impact-assessment\">Commercial Impact Assessment<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Revenue Exposure<\/strong>: Sinocare stated the affected products accounted for <strong>&lt;0.5% of total 2025 revenue<\/strong> in UPC jurisdictions<\/li>\n\n\n\n<li><strong>Market Presence<\/strong>: Limited commercial footprint in Europe compared to its dominant position in <strong>China, Southeast Asia, and Latin America<\/strong><\/li>\n\n\n\n<li><strong>Strategic Response<\/strong>: Company emphasized the ruling is <strong>interim and non-final<\/strong>, with plans to contest validity and infringement in the main proceedings<\/li>\n<\/ul>\n\n\n\n<p>\u201cWe do not expect this preliminary measure to have a material impact on our operations or financial performance,\u201d Sinocare said in a regulatory filing.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-industry-context\">Industry Context<\/h2>\n\n\n\n<p>The case underscores the <strong>heightened IP enforcement risk<\/strong> for Chinese medtech firms expanding into Europe under the new <strong>Unified Patent Court regime<\/strong>, which centralizes litigation across participating EU states. Abbott, a global leader in CGM with its <strong>FreeStyle Libre<\/strong> platform, has aggressively defended its IP portfolio worldwide\u2014including prior actions against <strong>Dexcom<\/strong> and <strong>Medtronic<\/strong>.<\/p>\n\n\n\n<p>For Sinocare, the injunction may accelerate efforts to <strong>redesign software architecture<\/strong> or pursue <strong>licensing discussions<\/strong>, though no such talks have been confirmed.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief summarizes legal developments and company disclosures. Final outcomes depend on the UPC\u2019s main infringement trial, patent validity challenges, and potential appeals. Financial impact remains subject to evolving market dynamics.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/\u4e09\u8bfa\u751f\u7269\uff1a\u5173\u4e8e\u4e0e\u96c5\u57f9\u5c31EP3988471\u4e13\u5229\u5728UPC\u8bc9\u8bbc\u7684\u516c\u544a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u4e09\u8bfa\u751f\u7269\uff1a\u5173\u4e8e\u4e0e\u96c5\u57f9\u5c31EP3988471\u4e13\u5229\u5728UPC\u8bc9\u8bbc\u7684\u516c\u544a.\"><\/object><a id=\"wp-block-file--media-89065e44-359d-46ed-b361-44db0e9857a4\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/\u4e09\u8bfa\u751f\u7269\uff1a\u5173\u4e8e\u4e0e\u96c5\u57f9\u5c31EP3988471\u4e13\u5229\u5728UPC\u8bc9\u8bbc\u7684\u516c\u544a.pdf\">\u4e09\u8bfa\u751f\u7269\uff1a\u5173\u4e8e\u4e0e\u96c5\u57f9\u5c31EP3988471\u4e13\u5229\u5728UPC\u8bc9\u8bbc\u7684\u516c\u544a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/04\/\u4e09\u8bfa\u751f\u7269\uff1a\u5173\u4e8e\u4e0e\u96c5\u57f9\u5c31EP3988471\u4e13\u5229\u5728UPC\u8bc9\u8bbc\u7684\u516c\u544a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-89065e44-359d-46ed-b361-44db0e9857a4\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Sinocare Inc. (SHE: 300298) disclosed that the Court of Appeal of the Unified Patent Court&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,61,22],"tags":[503,39,870,73,1683,1684],"class_list":["post-63651","post","type-post","status-publish","format-standard","hentry","category-company","category-legal-ip","category-medical-device","tag-abbott","tag-diabetes","tag-nyse-abt","tag-patents","tag-she-300298","tag-sinocare"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Sinocare Inc. (SHE: 300298) disclosed that the Court of Appeal of the Unified Patent Court (UPC) has overturned a prior decision by The Hague Local Division and granted a preliminary injunction against its iCanCGM App, citing alleged infringement of Abbott Laboratories\u2019 (NYSE: ABT) European Patent EP3988471. The injunction prohibits Sinocare from manufacturing, selling, or importing the disputed products across 17 UPC member states (excluding Romania), effective immediately.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=63651\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim\" \/>\n<meta property=\"og:description\" content=\"Sinocare Inc. (SHE: 300298) disclosed that the Court of Appeal of the Unified Patent Court (UPC) has overturned a prior decision by The Hague Local Division and granted a preliminary injunction against its iCanCGM App, citing alleged infringement of Abbott Laboratories\u2019 (NYSE: ABT) European Patent EP3988471. The injunction prohibits Sinocare from manufacturing, selling, or importing the disputed products across 17 UPC member states (excluding Romania), effective immediately.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=63651\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-21T13:27:51+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-21T13:27:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63651#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63651\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim\",\"datePublished\":\"2026-04-21T13:27:51+00:00\",\"dateModified\":\"2026-04-21T13:27:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63651\"},\"wordCount\":367,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Abbott\",\"Diabetes\",\"NYSE: ABT\",\"Patents\",\"SHE: 300298\",\"Sinocare\"],\"articleSection\":[\"Company\",\"Legal \\\/ IP\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=63651#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63651\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=63651\",\"name\":\"UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-04-21T13:27:51+00:00\",\"dateModified\":\"2026-04-21T13:27:52+00:00\",\"description\":\"Sinocare Inc. (SHE: 300298) disclosed that the Court of Appeal of the Unified Patent Court (UPC) has overturned a prior decision by The Hague Local Division and granted a preliminary injunction against its iCanCGM App, citing alleged infringement of Abbott Laboratories\u2019 (NYSE: ABT) European Patent EP3988471. The injunction prohibits Sinocare from manufacturing, selling, or importing the disputed products across 17 UPC member states (excluding Romania), effective immediately.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63651#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=63651\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=63651#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim - Insight, China&#039;s Pharmaceutical Industry","description":"Sinocare Inc. (SHE: 300298) disclosed that the Court of Appeal of the Unified Patent Court (UPC) has overturned a prior decision by The Hague Local Division and granted a preliminary injunction against its iCanCGM App, citing alleged infringement of Abbott Laboratories\u2019 (NYSE: ABT) European Patent EP3988471. The injunction prohibits Sinocare from manufacturing, selling, or importing the disputed products across 17 UPC member states (excluding Romania), effective immediately.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=63651","og_locale":"en_US","og_type":"article","og_title":"UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim","og_description":"Sinocare Inc. (SHE: 300298) disclosed that the Court of Appeal of the Unified Patent Court (UPC) has overturned a prior decision by The Hague Local Division and granted a preliminary injunction against its iCanCGM App, citing alleged infringement of Abbott Laboratories\u2019 (NYSE: ABT) European Patent EP3988471. The injunction prohibits Sinocare from manufacturing, selling, or importing the disputed products across 17 UPC member states (excluding Romania), effective immediately.","og_url":"https:\/\/flcube.com\/?p=63651","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-04-21T13:27:51+00:00","article_modified_time":"2026-04-21T13:27:52+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=63651#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=63651"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim","datePublished":"2026-04-21T13:27:51+00:00","dateModified":"2026-04-21T13:27:52+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=63651"},"wordCount":367,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Abbott","Diabetes","NYSE: ABT","Patents","SHE: 300298","Sinocare"],"articleSection":["Company","Legal \/ IP","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=63651#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=63651","url":"https:\/\/flcube.com\/?p=63651","name":"UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-04-21T13:27:51+00:00","dateModified":"2026-04-21T13:27:52+00:00","description":"Sinocare Inc. (SHE: 300298) disclosed that the Court of Appeal of the Unified Patent Court (UPC) has overturned a prior decision by The Hague Local Division and granted a preliminary injunction against its iCanCGM App, citing alleged infringement of Abbott Laboratories\u2019 (NYSE: ABT) European Patent EP3988471. The injunction prohibits Sinocare from manufacturing, selling, or importing the disputed products across 17 UPC member states (excluding Romania), effective immediately.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=63651#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=63651"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=63651#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"UPC Appeal Court Reverses Lower Ruling, Imposes Preliminary Injunction on Sinocare\u2019s iCanCGM App in 17 European Countries Following Abbott Patent Claim"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=63651"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63651\/revisions"}],"predecessor-version":[{"id":63653,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/63651\/revisions\/63653"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=63651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=63651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=63651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}